Sysmex Corporation

OTCPK:SSMX.F Stock Report

Market Cap: US$6.0b

Sysmex Valuation

Is SSMX.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of SSMX.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: SSMX.F ($9.35) is trading above our estimate of future cash flow value ($7.88)

Significantly Below Future Cash Flow Value: SSMX.F is trading above our estimate of future cash flow value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SSMX.F?

Key metric: As SSMX.F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SSMX.F. This is calculated by dividing SSMX.F's market cap by their current earnings.
What is SSMX.F's PE Ratio?
PE Ratio20.3x
EarningsJP¥44.75b
Market CapJP¥941.31b

Price to Earnings Ratio vs Peers

How does SSMX.F's PE Ratio compare to its peers?

The above table shows the PE ratio for SSMX.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average61.8x
TFX Teleflex
84.5x48.46%US$5.0b
NVST Envista Holdings
90.7x36.20%US$4.4b
MASI Masimo
44.1x12.37%US$9.2b
ITGR Integer Holdings
27.9x21.61%US$2.9b
SSMX.F Sysmex
20.3x11.70%US$941.3b

Price-To-Earnings vs Peers: SSMX.F is good value based on its Price-To-Earnings Ratio (20.3x) compared to the peer average (61.8x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does SSMX.F's PE Ratio compare vs other companies in the US Medical Equipment Industry?

4 CompaniesPrice / EarningsEstimated GrowthMarket Cap
EMBC Embecta
3.9x5.68%US$546.60m
ADVB Advanced Biomed
1.7xn/aUS$6.75m
MHUA.F Meihua International Medical Technologies
0.7xn/aUS$6.57m
ARTH.Q Arch Therapeutics
n/an/aUS$4.00
No more companies available in this PE range
SSMX.F 20.3xIndustry Avg. 27.2xNo. of Companies9PE020406080100+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SSMX.F is good value based on its Price-To-Earnings Ratio (20.3x) compared to the US Medical Equipment industry average (27.2x).

Price to Earnings Ratio vs Fair Ratio

What is SSMX.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SSMX.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.3x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SSMX.F's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SSMX.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$9.35
US$13.31
+42.37%
25.06%US$20.90US$8.23n/a15
Mar ’27US$8.97
US$14.02
+56.29%
24.94%US$21.17US$8.34n/a15
Feb ’27n/a
US$15.31
0%
21.82%US$21.55US$10.78n/a16
Jan ’27US$9.88
US$15.06
+52.47%
21.82%US$21.19US$10.60n/a16
Dec ’26US$9.60
US$15.44
+60.82%
21.06%US$21.14US$10.57n/a16
Nov ’26n/a
US$17.55
0%
16.07%US$23.67US$12.63n/a16
Oct ’26n/a
US$18.70
0%
13.63%US$24.47US$14.96n/a16
Sep ’26US$12.50
US$19.19
+53.50%
13.24%US$24.50US$14.97n/a16
Aug ’26n/a
US$20.84
0%
8.92%US$24.42US$16.82n/a15
Jul ’26US$15.00
US$21.48
+43.20%
8.87%US$24.87US$17.13n/a15
Jun ’26US$14.85
US$22.47
+51.32%
12.68%US$27.02US$17.18n/a16
May ’26US$16.24
US$23.38
+43.99%
11.36%US$27.45US$18.65n/a15
Apr ’26US$19.34
US$22.34
+15.53%
9.52%US$25.82US$19.86n/a14
Mar ’26n/a
US$22.62
0%
10.38%US$26.06US$20.05US$8.9714
Feb ’26n/a
US$21.43
0%
11.33%US$24.98US$16.84n/a14
Jan ’26n/a
US$21.80
0%
11.07%US$25.38US$17.12US$9.8814
Dec ’25n/a
US$22.23
0%
10.37%US$26.06US$17.57US$9.6014
Nov ’25n/a
US$20.48
0%
12.00%US$24.79US$17.16n/a14
Oct ’25US$20.27
US$21.27
+4.92%
11.74%US$25.05US$17.39n/a15
Sep ’25US$17.79
US$20.67
+16.19%
11.19%US$24.15US$16.77US$12.5014
Aug ’25n/a
US$20.02
0%
12.42%US$23.40US$16.01n/a14
Jul ’25US$14.75
US$19.88
+34.80%
12.76%US$23.17US$15.85US$15.0014
Jun ’25n/a
US$19.49
0%
12.73%US$23.30US$15.94US$14.8512
May ’25n/a
US$19.78
0%
12.04%US$23.70US$16.21US$16.2413
Apr ’25n/a
US$20.15
0%
12.04%US$24.15US$16.30US$19.3413
Mar ’25n/a
US$20.25
0%
11.97%US$24.26US$16.37n/a13
US$13.47
Fair Value
30.6% undervalued intrinsic discount
15
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/11 13:06
End of Day Share Price 2026/03/05 00:00
Earnings2025/12/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sysmex Corporation is covered by 29 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masahiro NakanomyoBarclays
Kei TakeuchiBofA Global Research
Ritsuo WatanabeBofA Global Research